$BIXT News

BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT

Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M

Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19

Bioxytran Initiates Research Collaboration with University of Georgia to Evaluate Drug Candidate's Ability to Block H5N1 Bird Flu Virus

Bioxytran, Inc. Announces Commercial Distribution Agreement with Khoury Medical LTD for A-SUQAR Dietary Supplement

Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran

Bioxytran Reports Phase 2 Results Showing 100% Viral Clearance By Day 7 In Randomized Double-Blind Placebo-Controlled ProLectin-M Trial (p=.001)

Bioxytran Reports Phase 2 Results Showing 100% Viral Clearance By Day 7 In Randomized Double-Blind Placebo-Controlled ProLectin-M Trial (p=.001)

Bioxytran CEO David Platt, Ph.D. to Present at Noble Capital Markets' Emerging Growth Virtual Equity Conference

Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics

Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline

Bioxytran Announces Initiation of Coverage of its Stock by Independent Research

Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug

Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation

Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment

Bioxytran Secures a Source of GMP Quality Camel Hemoglobin

Bioxytran’s Groundbreaking Stroke & Alzheimer’s Tech Gains Validation That Measures Oxygenation Uptake During Strokes

Bioxytran’s Antiviral Breakthrough Featured in University of Georgia’s $100M HPAI Poultry Innovation Grand Challenge Submission

Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M

Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements